Aquatic Capital Management LLC Has $3.10 Million Stock Holdings in The Clorox Company (NYSE:CLX)

Aquatic Capital Management LLC lowered its stake in The Clorox Company (NYSE:CLX) by 90.4% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 19,080 shares of the company’s stock after selling 179,120 shares during the period. Aquatic Capital Management LLC’s holdings in Clorox were worth $3,099,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of CLX. Norges Bank acquired a new position in shares of Clorox in the fourth quarter valued at approximately $259,041,000. FMR LLC grew its holdings in Clorox by 75.4% in the 4th quarter. FMR LLC now owns 1,361,758 shares of the company’s stock valued at $221,163,000 after buying an additional 585,526 shares in the last quarter. Marshall Wace LLP increased its position in Clorox by 549.8% during the 4th quarter. Marshall Wace LLP now owns 542,726 shares of the company’s stock worth $88,144,000 after buying an additional 459,203 shares during the period. ExodusPoint Capital Management LP lifted its holdings in shares of Clorox by 187.9% during the fourth quarter. ExodusPoint Capital Management LP now owns 698,900 shares of the company’s stock worth $113,508,000 after buying an additional 456,114 shares in the last quarter. Finally, Amundi boosted its position in shares of Clorox by 42.6% in the fourth quarter. Amundi now owns 1,032,283 shares of the company’s stock valued at $165,816,000 after acquiring an additional 308,234 shares during the period. 78.53% of the stock is owned by institutional investors.

Clorox Stock Up 0.5 %

Shares of NYSE CLX opened at $138.28 on Monday. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37. The company has a 50 day simple moving average of $145.61 and a 200 day simple moving average of $155.63. The firm has a market cap of $17.03 billion, a PE ratio of 37.78, a price-to-earnings-growth ratio of 2.62 and a beta of 0.61.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter in the prior year, the business earned $2.16 earnings per share. On average, research analysts forecast that The Clorox Company will post 7.15 EPS for the current year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd will be issued a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, April 23rd. This represents a $4.88 dividend on an annualized basis and a yield of 3.53%. Clorox’s payout ratio is currently 133.33%.

Analyst Upgrades and Downgrades

CLX has been the topic of a number of recent research reports. StockNews.com lowered shares of Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. Wells Fargo & Company lowered their target price on shares of Clorox from $155.00 to $145.00 and set an “equal weight” rating on the stock in a report on Wednesday, April 16th. Citigroup cut their price target on Clorox from $165.00 to $150.00 and set a “neutral” rating for the company in a research note on Monday, April 14th. UBS Group lowered their price objective on Clorox from $176.00 to $154.00 and set a “neutral” rating on the stock in a research note on Thursday, April 17th. Finally, Royal Bank of Canada reissued a “sector perform” rating and set a $150.00 target price on shares of Clorox in a report on Thursday, January 30th. Three equities research analysts have rated the stock with a sell rating, ten have given a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat, Clorox has an average rating of “Hold” and a consensus price target of $153.83.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.